Chemotherapy and radiotherapy: cryptic anticancer vaccines.
about
Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionThe potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapyImmunotherapy for prostate cancer: recent developments and future challengesCombining radiation and immunotherapy: a new systemic therapy for solid tumors?Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccinesCombining radiotherapy and cancer immunotherapy: a paradigm shiftMonoclonal antibodies for the treatment of cancerThe efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunityIs tumor (R)ejection by the immune system the "5th R" of radiobiology?Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsAt the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations.Oncogene withdrawal engages the immune system to induce sustained cancer regression.Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients.Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response.Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies.Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy.Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsetsHER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression.Immune microenvironments in solid tumors: new targets for therapy.TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor ImmunityRadiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine.A systematic review of the association between immunogenomic markers and cancer-related fatigueThe convergence of radiation and immunogenic cell death signaling pathways.Role of T lymphocytes in tumor response to radiotherapy.Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancerThe determinants of tumour immunogenicity.Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapiesModulation of dendritic cell function by the radiation-mediated secretory protein γ-synuclein.Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model.Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes.Contribution of the immune system to the chemotherapeutic response.
P2860
Q26775189-E073ADC3-654E-48E2-AAA8-8CE4B6D46A5AQ26783291-2B161C9A-2BB5-4A95-A8A5-F9EEAB6CC330Q26852388-B4AA59E1-99C6-4241-A844-330A83EDED53Q26991721-A1FA5069-833F-41A8-986A-D428E105424DQ27008070-D766D897-D757-4E63-BAF9-2C04BC736B35Q27021428-3C0C76BD-684C-4C36-8E54-74057D963304Q27025966-AE6BE35A-FFAF-405A-9021-B102B1A0E383Q28304923-F618541A-BDC5-4E85-B921-004FF6D64972Q33560039-311141AC-DAE7-48EF-A24C-14272F04DA30Q33698419-2CE3D3C5-1807-4488-A14D-07B279C4FE2AQ33732329-F98C9F36-F802-425E-9CC7-DD86F4AA0C4BQ33779875-B7E08A63-8C05-4A2F-9793-8DEE44BCF6DAQ33987633-EC906FD4-F769-4AD2-AA7F-2E09E9F1DB3FQ34180248-4CFBB9DE-0833-48BD-8AE5-7407FE18DA95Q34278609-3BAD1DA2-DEE0-4A96-9AB3-9B41168D2144Q34333155-B9E175B8-4730-4C4D-B1EA-713BD47AA71BQ34361976-619CB581-BA22-4B45-BC1E-D1A258E4443CQ34652570-29429375-4B1D-45B6-BEA0-C4AAE5AE67A7Q34764685-CA8F2686-3109-40DB-8FBE-25B75E13800EQ34898280-9CA34644-8F05-464A-87F2-6D4503BD78C9Q35024484-F836326B-7EBE-427F-A2B7-8446541C0F2FQ35059990-786BDA0F-1263-47E8-A314-B07A9C4A91C7Q35083126-A52DFF39-CCD2-46FC-9061-74999CE6B214Q35556207-0D9C3CD3-3222-4333-98B2-D3AF2012C10FQ35584269-D05234C8-E03E-4258-878A-2496E3DC2FB9Q35642044-551C3908-B989-4F49-8F6B-DC6675A353FCQ35908369-98A277E3-AA2E-42E2-82A5-854934FDB4DDQ35939457-8E21FA23-1738-410E-981D-E87FCD6BFBE9Q36098741-1314FBC6-DBE0-4BFB-A2DC-1205B54B6732Q36144356-525A240C-33DD-4258-9A29-737D281FD6BEQ36186619-4E9429AD-E302-44C6-8C3B-48CD98B63631Q36476394-F4F818DB-B005-4169-92E8-F40EDE5CE184Q36555524-89AEEC35-B61E-4581-8D36-8650E9BB24DFQ37047061-A5140787-ADF4-4FAC-B7FA-DAE70A37DE3BQ37164196-B14A5D46-B1B8-4259-8B3B-3B466696CC0CQ37338005-1E3D9F5B-0C7C-45C8-8A23-6916676CD44FQ37373689-E66B7FCC-784E-4AAF-9098-13FC3668892FQ37482728-38918578-D96F-438C-8884-A0A152C00133Q37699273-EEE8CB00-0CC7-47B0-AE79-CC4C4F12E56CQ37832967-474E18AF-0266-4572-BE71-46C17CF9E2C4
P2860
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@en
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@nl
type
label
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@en
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@nl
prefLabel
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@en
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@nl
P50
P1476
Chemotherapy and radiotherapy: cryptic anticancer vaccines.
@en
P2093
Nicole M Haynes
P304
P356
10.1016/J.SMIM.2010.03.001
P50
P577
2010-04-18T00:00:00Z